Insider Shareholders with Direct Ownership of Soleno Therapeutics Inc (SLNO)
This section provides a comprehensive overview of the insiders with direct ownership of Soleno Therapeutics Inc (SLNO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
SOLENO THERAPEUTICS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Bhatnagar Anish
CHIEF EXECUTIVE OFFICER |
1,230,245 | 554,724 | 719,553 $39.3 Million | 19 |
Oct 01, 2024
Reduced 0.31%
|
| 1,139,218 | 12,223 | 193,066 $10.5 Million | 11 |
Jun 06, 2024
Added 3.26%
|
|
|
James H Mackaness
CHIEF FINANCIAL OFFICER |
265,688 | 93,705 | 119,172 $6.51 Million | 19 |
Oct 01, 2024
Reduced 0.69%
|
| 157,149 | 59,454 | 108,932 $5.95 Million | 18 |
Oct 01, 2024
Reduced 0.29%
|
|
| 156,047 | 84,713 | 81,465 $4.45 Million | 18 |
Oct 01, 2024
Reduced 0.39%
|
|
|
Meredith Manning
Chief Commercial Officer |
40,000 | 0 | 40,000 $2.18 Million | 1 |
Jul 17, 2024
Added 50.0%
|
|
Michael F. Huang
Sr. VP of Clinical Development |
35,000 | 0 | 35,000 $1.91 Million | 1 |
Jul 17, 2024
Added 50.0%
|
| 112,719 | 33,567 | 15,401 $840,740 | 13 |
Jun 06, 2024
Added 29.68%
|
|
| 96,579 | 0 | 13,545 $739,421 | 7 |
Jun 06, 2024
Added 32.43%
|
|
| 13,000 | 0 | 13,000 $709,670 | 1 |
Aug 15, 2024
Added 50.0%
|
|
| 6,500 | 0 | 6,500 $354,835 | 1 |
Jun 06, 2024
Added 50.0%
|
|
| 6,500 | 0 | 6,500 $354,835 | 1 |
Jun 06, 2024
Added 50.0%
|